Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Glucocorticoids are powerful anti-inflammatory drugs that must be used carefully to avoid serious side effects.

Vitamin D has potential benefits for cancer prevention, heart health, diabetes, obesity, muscle function, skin health, and immune function, but clinical results are mixed and more research is needed.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

HPT axis hormones boost mitochondrial function and growth in hair follicles, potentially aiding hair health.

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.

A new method effectively predicts estrogen-related health effects for early screening.

Androgen receptors are active in many tissues of both male and female mice, not just reproductive organs.

Early hormones shape sex-specific differences in rat glands.

DHEA affects multiple receptors and may help with metabolic issues, but its safety and effectiveness in humans are unclear.

Finasteride, a hair loss drug, may cause long-term sexual side effects due to changes in hormone receptor levels.

Delta-opioid receptors affect skin cell circadian rhythms, possibly impacting wound healing and cancer.

Thyroid issues can cause alopecia areata.

Metformin works better for adolescent girls with PCOS who have certain genetic variations.

Lysophospholipids can act as anti-inflammatory agents through specific receptors, but more research is needed.

TLR4 is important in aging-related diseases and could be a new treatment target.

As skin cells mature, vitamin D receptor levels decrease while retinoid X receptor α levels increase.

RORA affects hair follicle stem cells' structure and movement, potentially helping treat hair loss.

PPAR-γ signaling improves mitochondrial function in hair follicles, potentially affecting hair growth and aging.

Skin changes can help diagnose and manage endocrine disorders like thyroid problems, diabetes, and adrenal gland conditions.

Natural compounds may help treat advanced papillary thyroid cancer by targeting specific molecular pathways.

Pioglitazone may help treat lichen planopilaris, but more research is needed.

Lipocalin-Type Prostaglandin D2 Synthase (L-PGDS) is a protein that plays many roles in the body, including sleep regulation, pain management, food intake, and protection against harmful substances. It also affects fat metabolism, glucose intolerance, cell maturation, and is involved in various diseases like diabetes, cancer, and arthritis. It can influence sex organ development and embryonic cell differentiation, and its levels can be used as a diagnostic marker for certain conditions.

Tirzepatide may improve hair loss by reducing insulin resistance.

Testosterone is key for male sexual function, and treating hormone imbalances can improve sexual issues.

DHEA affects various tissues by interacting with multiple receptors and can be converted into sex hormones.

Syndecan-1 is essential for maintaining skin fat and preventing cold stress.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

TNFα, IFNγ, and Substance P significantly affect prolactin levels in human skin, suggesting new treatments for skin and hair conditions.